We are live on
!
Find out more
SAM
Smithbridge Asset Management Portfolio holdings
AUM
$674M
1-Year Est. Return
26.11%
This Fund
S&P 500
This Quarter
Est. Return
+11.6%
1 Year Est. Return
+26.11%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$572M
AUM Growth
+$32.3M
(+6%)
Cap. Flow
-$11.7M
Cap. Flow
% of AUM
-2.04%
Top 10 Holdings %
Top 10 Hldgs %
33.34%
Holding
129
New
3
Increased
36
Reduced
62
Closed
7
Top Buys
| 1 |
Take-Two Interactive
TTWO
|
+$6.39M |
| 2 |
Royal Caribbean
RCL
|
+$5.96M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$3.78M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$2.73M |
| 5 |
Schwab US Dividend Equity ETF
SCHD
|
+$1.58M |
Top Sells
| 1 |
Applovin
APP
|
+$8.22M |
| 2 |
Schwab US Mid-Cap ETF
SCHM
|
+$4.77M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$3.4M |
| 4 |
Nike
NKE
|
+$2.22M |
| 5 |
WisdomTree US SmallCap Earnings Fund
EES
|
+$1.77M |
Sector Composition
| 1 | Technology | 24.3% |
| 2 | Healthcare | 12.6% |
| 3 | Industrials | 11.08% |
| 4 | Financials | 10.38% |
| 5 | Communication Services | 8.25% |
Similar funds
RCM
GCIA
DPC
BFA
CCM
CHCM
REST
MCM
Smithbridge Asset Management's Q2 2025 Portfolio in Review
As of Q2 2025, Smithbridge Asset Management held 129 positions worth $572M, up 6% from $540M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Smithbridge Asset Management's Q2 2025 filing shows 3 new, 36 increased, 62 reduced and 7 closed positions. Its largest new stake was Take-Two Interactive: 28,368 shares worth $6.89M. The largest sale was Applovin, an estimated $8.22M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.
- Smithbridge Asset Management's largest Q2 2025 buy was Take-Two Interactive: 28,368 shares worth $6.89M.
- Smithbridge Asset Management added most to iShares Core S&P Mid-Cap ETF in Q2 2025, an estimated $3.78M increase.
- Smithbridge Asset Management's biggest Q2 2025 reduction was Applovin, cutting an estimated $8.22M.
- Smithbridge Asset Management fully exited Regeneron Pharmaceuticals in Q2 2025, selling an estimated $3.4M.
- Smithbridge Asset Management's ten largest holdings make up 33% of its $572M portfolio in Q2 2025.
- Smithbridge Asset Management opened 3 new positions and closed 7 in Q2 2025.
- Smithbridge Asset Management's portfolio value rose 6% quarter-over-quarter to $572M.
Based on Smithbridge Asset Management's 13F filing for Q2 2025, filed 29 Jul 2025.